Analysis of a murine model of the AML1-ETO translocation
AML1-ETO 易位小鼠模型分析
基本信息
- 批准号:7844516
- 负责人:
- 金额:$ 0.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-01 至 2009-10-31
- 项目状态:已结题
- 来源:
- 关键词:AML1-ETO fusion proteinAcute Myelocytic LeukemiaAcute leukemiaAddressAnimalsBone MarrowCell CountCell LineageCellsChromosome abnormalityChromosomes, Human, Pair 21Chromosomes, Human, Pair 8Core-Binding FactorCytokine Receptor GeneDNA BindingDataDefectDevelopmentDiseaseEmbryoEtiologyExhibitsFunctional disorderGenesGeneticGoalsGrowth FactorHematopoiesisHematopoietic stem cellsHomeostasisHumanHuman ChromosomesIn VitroLeukocyte ElastaseLiverMaintenanceMetamyelocyteModelingMolecularMusMutationMyelocyteMyelogenousMyeloid CellsNuclearPathway interactionsPatientsPeripheralPeroxidasesPhenotypePlayProteinsRUNX1 geneRoleSamplingSpleenStem cellsT-Cell DevelopmentTissuesTransplantationbasecandidate identificationdomain mappingeosinophilknockout geneleukemiamyeloblastreconstitutionresearch studyretroviral transductionself-renewalt(821)(q22q22)transcription factor
项目摘要
DESCRIPTION (provided by applicant): The t(8;21)(q22;q22) translocation, which fuses the ETO gene on human chromosome 8 with the AML1 gene on chromosome 21, is one of the most frequent cytogenetic abnormalities associated with acute myeloid leukemia (AML). It is seen in approximately 12-15 percent of AML cases and is present in about 40 percent of AML with an M2 phenotype. We have generated a murine model of the t(8;21) by retroviral transduction of purified hematopoietic stem cells (HSC). Mice reconstituted with HSC that express AML 1- ETO show distinct developmental abnormalities in the stem cell compartment and within the myeloid lineages. Primitive myeloblasts were increased to approximately 10 percent of bone marrow by ten months post-transplant. Consistent with this observation was a 50-fold increase in myeloid colony forming cells in vitro. Eosinophil myelocytes that exhibited abnormal basophilic granulation were also increased. HSC numbers in the bone marrow of 10-month-old reconstituted animals were 29-fold greater than in transplant-matched control mice, suggesting that AML1-ETO expression overrides the normal genetic control of HSC pool size. In summary, AML1-ETO-expressing animals recapitulate many (and perhaps all) of the developmental abnormalities seen in human patients with the t(8;21), although the animals do not develop leukemia or disseminated disease in peripheral tissues like the liver or spleen. This suggests that secondary mutations are required to progress to acute leukemia. The primary goal of this proposal is to understand the underlying molecular and cellular basis for the developmental dysfunction caused by AML1-ETO expression in HSC. The specific aims will focus on (1), phenotypic and functional characterization of AML1-ETO expressing myeloblasts (2), determining the influence of AML1-ETO on HSC self renewal and identification of candidate self-renewal genes (3), characterization of secondary mutations that cooperate with AML1-ETO to induce AML and (4), functional mapping of domains within ETO that are responsible for the developmental phenotypes observed in HSC and myeloblasts.
描述(由申请人提供):t(8;21)(q22;q22)易位融合了人8号染色体上的ETO基因和21号染色体上的AML 1基因,是与急性髓性白血病(AML)相关的最常见的细胞遗传学异常之一。它见于大约12- 15%的AML病例,并且存在于大约40%的M2表型AML中。我们通过逆转录病毒转导纯化的造血干细胞(HSC)产生了t(8;21)的小鼠模型。用表达AML 1- ETO的HSC重建的小鼠在干细胞区室和髓系内显示出明显的发育异常。移植后10个月,原始成髓细胞增加到骨髓的约10%。与该观察结果一致的是体外髓系集落形成细胞增加50倍。表现出异常嗜碱性肉芽的嗜酸性粒细胞也增加。10个月大的重组动物骨髓中的HSC数量是移植匹配对照小鼠的29倍,表明AML 1-ETO表达超过了HSC池大小的正常遗传控制。总之,表达AML 1-ETO的动物重现了t(8;21)人类患者中观察到的许多(也许是所有)发育异常,尽管这些动物不会发生白血病或外周组织(如肝脏或脾脏)中的播散性疾病。这表明继发性突变是发展为急性白血病所必需的。本提案的主要目标是了解AML 1-ETO在HSC中表达引起的发育功能障碍的潜在分子和细胞基础。具体目标将集中在(1),表达AML 1-ETO的成髓细胞的表型和功能表征(2),确定AML 1-ETO对HSC自我更新的影响并鉴定候选自我更新基因(3),表征与AML 1-ETO协同诱导AML的继发突变和(4),ETO内负责HSC和成髓细胞中观察到的发育表型的结构域的功能定位。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER KLUG其他文献
CHRISTOPHER KLUG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER KLUG', 18)}}的其他基金
Defining the role of Wnt11 and Wnt5a in regulating hematopoietic and skeletal stem cell self-renewal potential during homeostasis and stress
定义 Wnt11 和 Wnt5a 在稳态和应激过程中调节造血和骨骼干细胞自我更新潜力的作用
- 批准号:
10731650 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Defining pathways promoting HSC self-renewal by mesenchymal stem/stromal cells
定义间充质干细胞/基质细胞促进 HSC 自我更新的途径
- 批准号:
9126155 - 财政年份:2015
- 资助金额:
$ 0.8万 - 项目类别:
Regulation of hematopoietic stem cell self-renewal by NUP98-HOXA9
NUP98-HOXA9对造血干细胞自我更新的调控
- 批准号:
8269740 - 财政年份:2010
- 资助金额:
$ 0.8万 - 项目类别:
Regulation of hematopoietic stem cell self-renewal by NUP98-HOXA9
NUP98-HOXA9对造血干细胞自我更新的调控
- 批准号:
8471160 - 财政年份:2010
- 资助金额:
$ 0.8万 - 项目类别:
Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation
NF-kB 在造血干细胞和白血病起始细胞形成中的作用
- 批准号:
8022931 - 财政年份:2010
- 资助金额:
$ 0.8万 - 项目类别:
Regulation of hematopoietic stem cell self-renewal by NUP98-HOXA9
NUP98-HOXA9对造血干细胞自我更新的调控
- 批准号:
8006300 - 财政年份:2010
- 资助金额:
$ 0.8万 - 项目类别:
Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation
NF-kB 在造血干细胞和白血病起始细胞形成中的作用
- 批准号:
8433499 - 财政年份:2010
- 资助金额:
$ 0.8万 - 项目类别:
Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation
NF-kB 在造血干细胞和白血病起始细胞形成中的作用
- 批准号:
8607152 - 财政年份:2010
- 资助金额:
$ 0.8万 - 项目类别:
Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation
NF-kB 在造血干细胞和白血病起始细胞形成中的作用
- 批准号:
8213544 - 财政年份:2010
- 资助金额:
$ 0.8万 - 项目类别:
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma
早期检测胰腺导管腺癌的生物标志物发现
- 批准号:
7962113 - 财政年份:2010
- 资助金额:
$ 0.8万 - 项目类别:
相似海外基金
Computing analysis of leukemic stem cell dynamics in acute myelocytic leukemia
急性粒细胞白血病白血病干细胞动力学的计算分析
- 批准号:
19K08356 - 财政年份:2019
- 资助金额:
$ 0.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of immunotoxins with super-targeting mAb in the acute myelocytic leukemia
在急性髓细胞白血病中使用超靶向单克隆抗体产生免疫毒素
- 批准号:
23501309 - 财政年份:2011
- 资助金额:
$ 0.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
DETERMINANTS OF RESPONSE OF ACUTE MYELOCYTIC LEUKEMIA
急性粒细胞白血病反应的决定因素
- 批准号:
3556971 - 财政年份:1980
- 资助金额:
$ 0.8万 - 项目类别:
DETERMINANTS OF RESPONSE OF ACUTE MYELOCYTIC LEUKEMIA
急性粒细胞白血病反应的决定因素
- 批准号:
3556968 - 财政年份:1980
- 资助金额:
$ 0.8万 - 项目类别:
ERADICATION OF ACUTE MYELOCYTIC LEUKEMIA CELLS BY MAB THERAPY
通过 MAB 疗法根除急性粒细胞白血病细胞
- 批准号:
3889304 - 财政年份:
- 资助金额:
$ 0.8万 - 项目类别:














{{item.name}}会员




